BioSig Technologies, Inc.
2 clinical trials · Sponsor
◉ Watch BioSig Technologies, Inc.
| Record | Firm | Date |
|---|---|---|
| Redo AF Sub Study (of the Pure EP 2.0 Main Study) (NCT04964440) | BioSig Technologies, Inc. | 2021-03-03 |
| Novel Cardiac Signal Processing System (NCT04112433) | BioSig Technologies, Inc. | 2019-11-12 |
Track BioSig Technologies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.